Selective CDK4/6 Inhibitors in Cancer: Moving Beyond Breast Cancer

Slideset - In this downloadable slideset, Richard Finn, MD, Gary K. Schwartz, MD, and Geoffrey Shapiro, MD, PhD provide insight on the rationale for targeting cyclin dependent kinases 4 and 6 in cancer and highlight emerging clinical data with selective CDK4/6 inhibitors in multiple cancers.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research